BNP PARIBAS FINANCIAL MARKETS - CONATUS PHARMACEUTICALS INC ownership

CONATUS PHARMACEUTICALS INC's ticker is CNAT and the CUSIP is 20600T108. A total of 40 filers reported holding CONATUS PHARMACEUTICALS INC in Q2 2019. The put-call ratio across all filers is 0.25 and the average weighting 0.0%.

Quarter-by-quarter ownership
BNP PARIBAS FINANCIAL MARKETS ownership history of CONATUS PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2020$3,000
-25.0%
100.0%0.00%
Q4 2019$4,000
-97.5%
10
-98.1%
0.00%
Q3 2019$163,000
+21.6%
5170.0%0.00%
Q2 2019$134,000
-72.7%
517
+13.9%
0.00%
Q1 2019$490,000
-37.6%
4540.0%0.00%
Q4 2018$785,000
-70.2%
4540.0%0.00%
Q3 2018$2,633,000
+35.5%
4540.0%0.00%
Q2 2018$1,943,000
-94.2%
454
-92.0%
0.00%
Q1 2018$33,242,000
+28.1%
5,663
+0.8%
0.00%
Q4 2017$25,960,000
+89.4%
5,619
+125.1%
0.00%
Q3 2017$13,703,000
-11.3%
2,496
-6.9%
0.00%
Q2 2017$15,443,0002,6810.00%
Other shareholders

There were no reported owners of CONATUS PHARMACEUTICALS INC in Q2 2019.

NameSharesValueWeighting ↓
View complete list of CONATUS PHARMACEUTICALS INC shareholders